Gainers

• HCW Biologics (NASDAQ:HCWB) stock increased by 211.6% to $1.05 during Friday's pre-market session. The market value of their outstanding shares is at $2.2 million. As per the news, the Q1 earnings report came out yesterday.
• P3 Health Partners (NASDAQ:PIII) stock rose 21.33% to $4.89. The company's market cap stands at $13.2 million. As per the news, the Q1 earnings report came out yesterday.
• Intelligent Bio Solutions (NASDAQ:INBS) stock increased by 12.65% to $4.63. The market value of their outstanding shares is at $8.9 million. The company's, Q3 earnings came out 2 days ago.
• Lifeward (NASDAQ:LFWD) shares moved upwards by 11.75% to $7.37. The market value of their outstanding shares is at $18.3 million. The company's, Q1 earnings came out today.
• Sol-Gel Technologies (NASDAQ:SLGL) stock rose 11.38% to $76.5. The market value of their outstanding shares is at $222.8 million.
• MiNK Therapeutics (NASDAQ:INKT) shares rose 9.89% to $11.55. The company's market cap stands at $49.3 million. The company's, Q1 earnings came out today.

Losers

• Aardvark Therapeutics (NASDAQ:AARD) shares decreased by 41.8% to $3.92 during Friday's pre-market session. The market value of their outstanding shares is at $146.8 million.
• Zentek (NASDAQ:ZTEK) stock declined by 25.79% to $0.75. The company's market cap stands at $108.6 million.
• Claritev (NYSE:CTEV) stock declined by 19.05% to $19.0. The company's market cap stands at $400.1 million.
• WORK Medical Tech Gr (NASDAQ:WOK) shares decreased by 17.72% to $1.07.
• Dare Bioscience (NASDAQ:DARE) shares decreased by 14.69% to $2.44. The market value of their outstanding shares is at $41.6 million. As per the press release, Q1 earnings came out yesterday.
• Galmed Pharmaceuticals (NASDAQ:GLMD) stock decreased by 13.43% to $0.57. The company's market cap stands at $4.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.